[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Patient Population of Malignant Mesothelioma to Increase to 2023, States DelveInsight in Its Report Available at MarketPublishers.com

30 Mar 2017 • by Natalie Aster

LONDON – The number of patients with malignant mesothelioma is forecast to gather speed through to 2023.

Pleural mesothelioma is the most typical form of mesothelioma, originating from the exposure to asbestos fibers. Around 70% of the cases of mesothelioma fall within the scope of this category.

Another type of the disease, peritoneal mesothelioma, have a bearing on the lining of abdomen; nearly 15-20 % mesothelioma cases occur as peritoneal.

Pericardial mesothelioma is a quite rare form affecting the heart lining, and is diagnosed in 1 % or even less number of cases. Another rare mesothelioma kind is tunic vaginalis, which affects the testicles.

Malignant mesothelioma is a fatal disease, with poor prognosis and the survival time after the initial diagnosis being close to 9-12 months.

In-demand research study “Malignant Mesothelioma - Market Insights, Epidemiology and Market Forecast – 2023 - EU5” elaborated by DelveInsight analyses the malignant mesothelioma therapeutics marketplace across the EU5.

The report presents an overview of the disease covering pathophysiology, types of the disease, signs and symptoms, diagnosis, staging of malignant mesothelioma, disease management, risk factors and present-day treatment options.

The study provides information on the available prescription drugs, detailing MoA, regulatory milestones, advantages and disadvantages, safety and efficacy, patent and exclusivity details. It offers a discussion of the leading companies. The report casts light on the clinical pipeline activity, offers information on ongoing trials and breaks down clinical trials by phase. The report provides an exhaustive analysis of the market size of malignant mesothelioma globally and for EU5 from 2010 and also forecasts the market size till 2023. For each country market, the study provides market size by disease sub-type. Furthermore, market drivers and restraints are identified and examined in the report.

More comprehensive reports by this publisher are available at the DelveInsight page


The Market Publishers, Ltd.
Natalie Aster
Tel: +44 208 144 6009
Fax: +44 207 900 3970
[email protected]

Analytics & News

Weekly Digest